{"pageContent": "Background: Androgen deprivation therapy (ADT) has become the cornerstone of treatment for men with metastatic prostate cancer. However, treatments are associated with a number of adverse effects that collectively are referred to as andropause syndrome, or the male menopause.", "metaData": {"source": "How potent is potent? Evaluation of sexual function and bother in men who report potency after treatment for prostate cancer: data from CaPSURE\nhttps://pubmed.ncbi.nlm.nih.gov/12559294/"}}